Xenocs raises ?3.5 million

Investee Company – Xenocs (France)

Investee Company Business Type – Manufactures optical multi-layers for the EUV (Extreme Ultra Violet) lithography technology

Type of Financing – Early Stage

Equity Providers – Siparex Ventures and ABN Anmro Capital France

Equity Leader (Individual) – Richard Vacher-Detourniere

Debt Providers – N/A

Debt Type – N/A

Debt Leader (Individual) – N/A

Equity Amount – €3.5 million

Total Deal Value – €3.5 million

Other Advisors – PriceWaterhouseCoopers (financial), Landwell & Ass. (legal)

Comments – Xenocs, a company specialising in providing innovative solutions for the design, development and manufacture of multi-layer EUV, X-ray and neutron optics has announced a capital increase of €3.5 million to finance its growth.

The company was backed by Siparex Ventures, who led the round, and ABN Amro Capital France. Siparex committed €2.5 million and ABN Amro €1 million.

Xenocs was spun out from the Institut Laue Langevin (ILL) by Peter Hoghoj, a former researcher, and two associates. The company’s technology stems directly from research done at ILL into developing the technology of multilayer for neutrons by perfecting a production tool and by controlling the manufacturing processes. ILL has granted Xenocs the exclusive license of this tyechnology.